Label Changes for:
Detrol (tolterodine tartrate tablets)
Changes have been made to the PRECAUTIONS and PATIENT PACKAGE INSERT sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- September 2008
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.|
- Decreased Gastrointestinal Motility
- Myasthenia Gravis
PATIENT PACKAGE INSERT
- What should I tell my doctor before starting Detrol?
- Before starting Detrol, tell your doctor about all of your medical conditions, including if you:
- have a condition called myasthenia gravis